The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis.
 
Antonio D'Alessio
No Relationships to Disclose
 
Arndt Weinmann
No Relationships to Disclose
 
Peter R. Galle
Honoraria - Adaptimmune; AstraZeneca/MedImmune; Bayer Schering Pharma; Boston Scientific; Bristol-Myers Squibb; Guerbet; Ipsen; Lilly; MSD; Roche/Genentech; Sirtex Medical
Consulting or Advisory Role - Adaptimmune; Bayer Schering Pharma; Boston Scientific; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech; Sirtex Medical
Speakers' Bureau - Bayer Schering Pharma; Ipsen; Lilly; Roche
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - Bayer Schering Pharma; Lilly; Sirtex Medical
 
Claudia Angela Maria Fulgenzi
No Relationships to Disclose
 
Dominik Bettinger
Consulting or Advisory Role - Boston Scientific
Speakers' Bureau - Bayer Health
 
Bertram Bengsch
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Amgen; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Lorenz Balcar
No Relationships to Disclose
 
Bernhard Scheiner
No Relationships to Disclose
 
Musharraf Navaid
No Relationships to Disclose
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
Nicola Personeni
Consulting or Advisory Role - Amgen; Merck Serono
Speakers' Bureau - Abbvie; Gilead Sciences; Lilly
Research Funding - Basilea (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen
 
Tiziana Pressiani
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst); Lilly (Inst)
 
Rohini Sharma
Consulting or Advisory Role - Bayer; Eisai; Roche; Sirtex Medical
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); Incyte (Inst); Novartis (Inst)
 
Matthias Pinter
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; MSD
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Eisai; Lilly
Research Funding - Bayer; Bristol-Myers Squibb; Lilly
Travel, Accommodations, Expenses - Bayer
 
Alessio Cortellini
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Speakers' Bureau - Astellas Pharma; AstraZeneca; MSD
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche; Sanofi
 
Lorenza Rimassa
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Eisai; Gilead Sciences; Incyte; Ipsen; Lilly; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Amgen; ArQule; AstraZeneca; Basilea; Baxter; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Exelixis; Genenta Science; Hengrui Therapeutics; Incyte; Ipsen; IQvia; Italfarmaco; Lilly; Merck Sharp & Dohme; Nerviano Medical Sciences; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Oncology; Zymeworks
Research Funding - Agios (Inst); ARMO BioSciences (Inst); ArQule (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Eisai (Inst); Exelixis (Inst); Exelixis/Ipsen (Inst); FibroGen (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Nerviano Medical Sciences (Inst); Roche; Zymeworks (Inst)
Travel, Accommodations, Expenses - ArQule; Ipsen
 
David James Pinato
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Da Volterra; Eisai; H3 Biomedicine; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline (Inst); MSD Oncology
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology